PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,077 | -42.6% | 116,914 | -30.8% | 0.00% | – |
| Q2 2023 | $338,000 | -50.9% | 169,000 | -48.4% | 0.00% | – |
| Q1 2023 | $688,271 | +160.6% | 327,748 | +70.0% | 0.00% | – |
| Q4 2022 | $264,146 | +146.9% | 192,807 | +88.2% | 0.00% | – |
| Q3 2022 | $107,000 | -10.8% | 102,457 | -7.0% | 0.00% | – |
| Q2 2022 | $120,000 | +140.0% | 110,115 | +136.3% | 0.00% | – |
| Q1 2022 | $50,000 | -23.1% | 46,600 | -40.1% | 0.00% | – |
| Q4 2021 | $65,000 | -75.9% | 77,815 | -61.6% | 0.00% | – |
| Q3 2021 | $270,000 | -61.5% | 202,545 | -44.9% | 0.00% | – |
| Q2 2021 | $701,000 | +91.5% | 367,386 | +347.1% | 0.00% | – |
| Q1 2021 | $366,000 | +320.7% | 82,172 | +241.0% | 0.00% | – |
| Q4 2020 | $87,000 | +4.8% | 24,100 | +12.1% | 0.00% | – |
| Q3 2020 | $83,000 | -39.0% | 21,500 | -39.9% | 0.00% | – |
| Q2 2020 | $136,000 | – | 35,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |